Riskpilot← Back to searchSign inGet full accessEir Diagnostics ApS
APSActiveCVR 40339396Grejsdalsvej 272Manufacture of medical and dental instruments and supplies · NACE 3250Est. 20191 employeeswww.eir-diagnostics.com
Revenue 2024
DKK -13K
-101% vs 2023
EBITDA margin
1058.1%
+67% vs 2023
Equity ratio
67.3%
Financial strength
Net profit 2024
DKK -456K
+10% vs 2023
| Revenue | DKK -13K | -101% |
| EBITDA | DKK -141K | +67% |
| Net profit | DKK -456K | +10% |
| Total assets | DKK 18,5M | +47% |
| Equity | DKK 12,4M | +65% |
| Employees | 1 | — |
Legal name
Eir Diagnostics ApS
CVR number
40339396
Legal form
Anpartsselskab
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
12. marts 2019
Share capital
DKK 108.461
Employees
1 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af bestyrelsens formand i forening med den administrerende direktør eller af den samlede bestyrelse.
Company purpose
Selskabets formål er at udvikle og kommercialisere patenter.
Address
Grejsdalsvej 272
Phone
+4551999005
Email
info@eir-diagnostics.com
Website
www.eir-diagnostics.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Revenue | 0 | 1.455 | 1.217 | 1.661 | 1.061 | -13 |
| Staff expenses | -988 | -1.928 | -1.879 | -2.504 | -1.485 | -128 |
| EBITDA | -328 | -473 | -662 | -843 | -424 | -141 |
| Depreciation & amort. | -0 | -0 | -0 | -23 | -58 | -58 |
| EBIT | -328 | -473 | -662 | -866 | -481 | -199 |
| Net financials | -96 | -139 | -7 | -120 | -249 | -322 |
| Profit before tax | -424 | -612 | -669 | -986 | -731 | -521 |
| Tax | 97 | -244 | -200 | -392 | -224 | -66 |
| Net profit | -327 | -369 | -469 | -594 | -507 | -456 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | 3.905 | 6.385 | 8.815 | 11.589 | 12.566 | 18.480 |
| Equity | 249 | 5.205 | 7.434 | 7.589 | 7.562 | 12.440 |
| Long-term debt | 3.193 | 0 | 0 | 499 | 523 | 957 |
| Short-term debt | 286 | 669 | 523 | 2.455 | 3.278 | 3.819 |
| Total debt | 3.479 | 669 | 523 | 2.953 | 3.801 | 4.776 |
EBITDA margin
-14122700.0%
This company
15.8%
Market median
-89384277% vs market
20192024
Equity ratio
67.3%
This company
38.2%
Market median
+76% vs market
20192024
Return on equity
-3.7%
This company
18.4%
Market median
-120% vs market
20192024
Net profit margin
-45565800.0%
This company
8.1%
Market median
-562540841% vs market
20192024
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
20192024
Debt / equity
0.49×
This company
0.62×
Market median
+21% vs market
20192024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-03-12 – 2019-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
NZ Management | Management | 2022 | — | — |
TW Chief Executive Officer | Chief Executive Officer | 2023 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2023 | — | — | |
| Board of Directors | 2019 | — | — | |
| Board of Directors | 2019 | — | — | |
| Board of Directors | 2019 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2019 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2024 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Apta Holding ApS | Company | 33.3% | 33.3% | 2019 |
PLASTISENS ApS | Company | 20.0% | 20.0% | 2024 |
Danmarks Tekniske Universitet | Company | 10.0% | 10.0% | 2024 |
| Individual | 5.0% | 5.0% | 2024 | |
KEMPHANSEN HOLDING ApS | Company | 5.0% | 5.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
KEMPHANSEN HOLDING ApS
Eir Diagnostics ApS Board members of Eir Diagnostics ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Noemi Zsuzsanna Rozlosnik | Management | 0 companies |
| Tine Walldén Jespersen | Chief Executive Officer | 0 companies |
| Kasper Hansen | Chairman | 0 companies |
| Ralf-Otto Busch | Board of Directors | 0 companies |
| Attila Sükösd | Board of Directors | 0 companies |
| Morten Sloth Olesen | Board of Directors | 0 companies |
| Preben Joffe | Board of Directors | 0 companies |
| Torsten Freltoft | Board of Directors | 0 companies |
| Johannes Dapra | Board of Directors | 0 companies |
| Morten Lodberg Petersen | Board of Directors | 0 companies |
| Michael Niels Døssing | Board of Directors | 0 companies |